Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential.
Huang R, Liu Z, Sun T, Zhu L.
Microbiol Res. 2024 Oct;287:127857. doi: 10.1016/j.micres.2024.127857. Epub 2024 Jul 26.
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.
Lim K, Small W Jr, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A; Gyn IMRT Consortium.
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):348-55. doi: 10.1016/j.ijrobp.2009.10.075. Epub 2010 May 14.
Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD; Costa Rica HPV Vaccine Trial (CVT) Group.
PLoS Pathog. 2020 Mar 26;16(3):e1008376. doi: 10.1371/journal.ppat.1008376. eCollection 2020 Mar.
A rare synchronous presentation of primary malignant melanoma in cervix and vagina.
Pai UKN, Pillai S, Arunkumar NR.
J Cancer Res Ther. 2023 Oct 1;19(7):2108-2110. doi: 10.4103/jcrt.jcrt_1309_21. Epub 2022 Apr 27.
Condylomatous lesions of the cervix and vagina. I. Cytologic patterns.
Meisels A, Fortin R.
Acta Cytol. 1976 Nov-Dec;20(6):505-9.
Atypical glandular lesions of the cervix and risk of cervical cancer.
Graue R, Lönnberg S, Skare GB, Saether SMM, Bjørge T.
Acta Obstet Gynecol Scand. 2020 May;99(5):582-590. doi: 10.1111/aogs.13790. Epub 2020 Jan 7.
Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK, Talluri AK, Maqbool A, Reddy D, Singareddy R, Sresty NM, Raju AK.
Brachytherapy. 2022 Mar-Apr;21(2):151-157. doi: 10.1016/j.brachy.2021.09.004. Epub 2021 Oct 28.
Primary malignant melanoma of the uterine cervix or vagina which were successfully treated with nivolumab.
Anko M, Nakamura M, Kobayashi Y, Tsuji K, Nakada S, Nakamura Y, Funakoshi T, Banno K, Aoki D.
J Obstet Gynaecol Res. 2020 Jan;46(1):190-195. doi: 10.1111/jog.14136. Epub 2019 Oct 14.
The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populations.
Baay M, Verhoeven V, Wouters K, Lardon F, Van Damme P, Avonts D, Van Marck E, Van Royen P, Vermorken JB.
Scand J Infect Dis. 2004;36(6-7):456-9. doi: 10.1080/00365540410020677.
A clinicopathologic study of vagina and cervix in DES-exposed progeny.
Zerner J, Fu YS, Taxiarchis LN, Reagan JW, Richart RM.
Diagn Gynecol Obstet. 1980 Winter;2(4):245-56.
